Showing results (221-230 of 228) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
American Heart Journal|July 1, 1986
Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failureK Dickstein, T Aarsland, L Woie, et al.Rheumatology International|January 1, 1997
Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritisD Nordström, Y Lindroth, L Marsal, et al.Life Sciences|January 1, 1989
Experimental ductus arteriosus: the relationships of atrial pressure, dilatation and flow with ANF secretionE Pesonen, F Sherman, J Breuer, et al.The European Respiratory Journal|November 1, 1990
Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosisC Prior, R A Barbee, P M Evans, et al.American Journal of Hypertension|July 1, 1997
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study GroupB Dahlöf, R Devereux, U de Faire, et al.American Journal of Hypertension|August 19, 2000
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For EndpointS E Kjeldsen, B Dahlöf, R B Devereux, et al.Hypertension (Dallas, Tex. : 1979)|December 18, 1998
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in HypertensionB Dahlöf, R B Devereux, S Julius, et al.Journal of Human Hypertension|April 23, 2004
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE studyH M Reims, S E Kjeldsen, W E Brady, et al.Pageof 23